NCT01341717View on ClinicalTrials.gov

Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin

PHASE4CompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Sitagliptin

100 mg once daily for 6 months

DRUG

Glimepiride

1 mg/2 mg/3 mg once daily

DRUG

Metformin

\>=1000 mg twice daily

DRUG

Insulin

TDD \> 10 IU once/twice daily

Trial Locations (1)

695032

Jothydev's Diabetes and Research Center, Thiruvananthapuram

All Listed Sponsors
lead

Jothydev's Diabetes and Research Centre

OTHER

NCT01341717 - Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin | Biotech Hunter | Biotech Hunter